BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16769975)

  • 1. Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon.
    Skromne E; Rivera VM; Ontaneda D; Ordonez L
    Neurology; 2006 Jun; 66(11):1787-8; author reply 1787-8. PubMed ID: 16769975
    [No Abstract]   [Full Text] [Related]  

  • 2. Progression of progressive multifocal leukoencephalopathy despite treatment with beta-interferon.
    Nath A; Venkataramana A; Reich DS; Cortese I; Major EO
    Neurology; 2006 Jan; 66(1):149-50. PubMed ID: 16401874
    [No Abstract]   [Full Text] [Related]  

  • 3. Progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy.
    Yoon CJ
    AIDS Read; 2006 Jun; 16(6):304-6, 309. PubMed ID: 16795920
    [No Abstract]   [Full Text] [Related]  

  • 4. Progressive multifocal leukoencephalopathy--progress made and lessons relearned.
    Greenlee JE
    N Engl J Med; 1998 May; 338(19):1378-80. PubMed ID: 9571261
    [No Abstract]   [Full Text] [Related]  

  • 5. A review of progressive multifocal leukoencephalopathy in persons with and without AIDS.
    Dworkin MS
    Curr Clin Top Infect Dis; 2002; 22():181-95. PubMed ID: 12520654
    [No Abstract]   [Full Text] [Related]  

  • 6. Mirtazapine use in human immunodeficiency virus-infected patients with progressive multifocal leukoencephalopathy.
    Cettomai D; McArthur JC
    Arch Neurol; 2009 Feb; 66(2):255-8. PubMed ID: 19204164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual complication of immunosuppression in myasthenia gravis: progressive multifocal leukoencephalopathy.
    Gedizlioglu M; Coban P; Ce P; Sivasli IE
    Neuromuscul Disord; 2009 Feb; 19(2):155-7. PubMed ID: 19054676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of progressive multifocal encephalopathy with highly active antiretroviral therapy.
    Baqi M; Kucharczyk W; Walmsley SL
    AIDS; 1997 Oct; 11(12):1526-7. PubMed ID: 9342080
    [No Abstract]   [Full Text] [Related]  

  • 9. Failure of cytarabine and increased JC virus-DNA burden in the cerebrospinal fluid of patients with AIDS-related progressive multifocal leucoencephalopathy.
    Antinori A; De Luca A; Ammassari A; Cingolani A; Murri R; Colosimo G; Roselli R; Scerrati M; Tamburrini E
    AIDS; 1994 Jul; 8(7):1022-4. PubMed ID: 7946093
    [No Abstract]   [Full Text] [Related]  

  • 10. Progressive multifocal leukoencephalopathy regression with highly active antiretroviral therapy.
    TeĆ³filo E; Gouveia J; Brotas V; da Costa P
    AIDS; 1998 Mar; 12(4):449. PubMed ID: 9520183
    [No Abstract]   [Full Text] [Related]  

  • 11. Progressive multifocal leukoencephalopathy, HIV, and highly active antiretroviral therapy.
    Cinque P; Casari S; Bertelli D
    N Engl J Med; 1998 Sep; 339(12):848-9. PubMed ID: 9750081
    [No Abstract]   [Full Text] [Related]  

  • 12. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencephalopathy despite highly active antiretroviral therapy.
    De Luca A; Ammassari A; Cingolani A; Giancola ML; Antinori A
    AIDS; 1998 Oct; 12(14):1937-8. PubMed ID: 9792402
    [No Abstract]   [Full Text] [Related]  

  • 13. The emergence of progressive multifocal leukoencephalopathy (PML) in rheumatic diseases.
    Boren EJ; Cheema GS; Naguwa SM; Ansari AA; Gershwin ME
    J Autoimmun; 2008; 30(1-2):90-8. PubMed ID: 18191544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Favourable outcome of progressive multifocal leukoencephalopathy with mefloquine treatment in combination with antiretroviral therapy in an HIV-infected patient.
    Adachi E; Koibuchi T; Imai K; Kikuchi T; Koga M; Nakamura H; Miura T; Iwamoto A; Fujii T
    Int J STD AIDS; 2012 Aug; 23(8):603-5. PubMed ID: 22930304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topotecan and PML: the limits of pharmaceutical industry research.
    Learned J
    Notes Undergr; 1996 Sep; (No 33):1-3. PubMed ID: 11363913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of infections by the human polyomavirus JC: past, present and future.
    Hou J; Major E
    Expert Rev Anti Infect Ther; 2005 Aug; 3(4):629-40. PubMed ID: 16107201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune reconstitution inflammatory syndrome associated with progressive multifocal leukoencephalopathy in a perinatally acquired human immunodeficiency virus-infected young adult.
    Ch'ng TW; Dieudonne A
    Pediatr Infect Dis J; 2007 Nov; 26(11):1068-70. PubMed ID: 17984821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New treatments for progressive multifocal leukoencephalopathy in HIV-1-infected patients.
    Sadler M; Chinn R; Healy J; Fisher M; Nelson MR; Gazzard BG
    AIDS; 1998 Mar; 12(5):533-5. PubMed ID: 9543455
    [No Abstract]   [Full Text] [Related]  

  • 19. Immune reconstitution inflammatory syndrome associated with PML in AIDS: a treatable disorder.
    Martinez JV; Mazziotti JV; Efron ED; Bonardo P; Jordan R; Sevlever G; Martinez M; Verbanaz SC; Salazar ZS; Pardal MF; Reisin R
    Neurology; 2006 Nov; 67(9):1692-4. PubMed ID: 17101910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive multifocal leukoencephalopathy in a patient with polymyositis: case report and literature review.
    Dastmalchi M; Laki J; Lundberg IE; Iacobaeus E
    J Rheumatol; 2012 Jun; 39(6):1299-303. PubMed ID: 22661423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.